Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
109.9 INR | -1.26% |
|
+6.96% | -11.80% |
Jun. 20 | Crisil Keeps BBB+ Rating on Bliss GVS Pharma's Bank Loans; Outlook Stable | MT |
May. 02 | Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bearish | Neutral |
Resistance | 114.00 | 115.85 | 146.33 |
Spread/Res. | -3.60% | -5.14% | -24.90% |
Spread/Supp. | +3.44% | +12.89% | +30.43% |
Support | 106.25 | 97.35 | 84.26 |
- Stock Market
- Equities
- BLISSGVS Stock
- Charts Bliss GVS Pharma Limited